Gary Lawton

life long supporter Liverpool FC, love Europe, Anti EU

[Gary Lawton @playno32]

Avacta update

#avct

Meet and engage with the companies you invest in https://t.co/q9SByJWzKz

[Gary Lawton @playno32]

Meet and engage with the companies you invest in https://t.co/fr46lb5a51

#avct

[Gary Lawton @playno32]

@SueNutt2 @TruthSignalUK @wolsned The registration plate prefix "DC" in the UK generally indicates that the vehicle was registered in the Middlesbrough area, specifically in the North East of England.

[Gary Lawton @playno32]

Manchester - Boa Vista 20 Dec 2024 - 03 Jan 2025

@Spare_Fare

[Gary Lawton @playno32]

@JamesMelville

[Gary Lawton @playno32]

@HighwaysNWEST @CheshireRCU Any updates, is it clear or are there still delays.

[Avacta @avacta]

Avacta is pleased to provide detailed pre-clinical, clinical and pharmacokinetic data from the Phase 1a dose escalation study of its lead pre|CISION programme, AVA6000, a tumour activated form of doxorubicin. https://t.co/OWNtJyHfvQ #AVCT

[Gary Lawton @playno32]

@earthcurated @nev_in_color

[Gary Lawton @playno32]

@Jenkoool https://t.co/U9ZDOCnbJT

[Avacta @avacta]

Successful Completion of ALS-6000-101 Sixth Dose Escalation and Clinical Update. https://t.co/PbM6XZtgi4 #AVCT

[Benonwine @benonwine]

Do you want the UK to rejoin the EU?

Please Retweet for a larger audience.

[Gary Lawton @playno32]

At last https://t.co/hHUj82FEEY

[Gary Lawton @playno32]

https://t.co/dEiimOyZ6z

#avct

[EvokedSet @EvokedSet]

The Knowledge Hub’s Ellie Bruni interviews @avacta’s CSO Dr Fiona McLaughlin at Bio International Convention in Boston:

▶️ https://t.co/KOZVLqL0Rt

#bio2023 #bio23 #cancertherapeutics #oncology #lifesciences #avacta

[Gary Lawton @playno32]

@that_stocks_guy None in stock at the moment

[Gary Lawton @playno32]

@BrockRiddickIFB All to do with ETOPS

[Gary Lawton @playno32]

Sunrise 🌅 this morning.
No stress.

[Gary Lawton @playno32]

@djnickuk @JenrobertsPR None.

[Vox Markets @VOXmarkets]

In this Podcast - Alastair Smith, CEO of Avacta #AVCT takes @VOXmarkets through yesterday's news with regards to the Phase 1a clinical trial data for AVA6000.

https://t.co/ZAPAKKyiN0 #investing #shares #voxmarkets @avacta via @VOXmarkets